Lifelong Treatment with Oral DHEA Sulfate Does Not Preserve Immune Function, Prevent Disease, or Improve Survival in Genetically Heterogeneous Mice

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-5415|47|8|960-966

ISSN： 0002-8614

Source： JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol.47, Iss.8, 1999-08, pp. : 960-966

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dilated cardiomyopathy: a genetically heterogeneous disease

By Shaw T.   Elliott P.   McKenna W.J.  

The Lancet, Vol. 360, Iss. 334, 2002-08 ,pp. : 654-655

Elsevier

Access to resources Recommend Favorite

Impact of DHEA(S) and cortisol on immune function in aging: a brief review

By Buford Thomas W.   Willoughby Darryn S.  

Applied Physiology, Nutrition, and Metabolism, Vol. 33, Iss. 3, 2008-06 ,pp. : 429-433

NRC Research Press

Access to resources Recommend Favorite

Huntington's disease phenocopies are clinically and genetically heterogeneous

By  

MOVEMENT DISORDERS, Vol. 23, Iss. 5, 2008-04 ,pp. : 716-720

John Wiley & Sons Inc

Access to resources Recommend Favorite

The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 36, Iss. 10, 2016-10 ,pp. : 1490-1497

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetically Modified T Cells for the Treatment of Malignant Disease

By  

Transfusion Medicine and Hemotherapy, Vol. 40, Iss. 6, 2013-11 ,pp. : 388-402

Karger

Access to resources Recommend Favorite